Texas Biologics
Focusing on the discovery, early development and clinical translation of biologic therapies with research at the cutting-edge of science, engineering and medicine.
Programs
Through our innovative programs, Texas Biologics is investing in every phase of biologic development, from research support to clinical evaluation to commercialization.
Current Projects
UT researchers are active in the development of new biologic therapies, including enzymes, antibodies, peptides and vaccines.
Partner With Us
There are many ways to engage with Texas Biologics, from academic collaboration to technology licensing to philanthropic support.
Pilot Grant and Science Studios Awardees
Texas Biologics awarded its latest round of Pilot Grants to accelerate biologic technology development. In partnership with Dell Med’s Health Transformation Research Institute, we also awarded the second cohort of Science Studios grants.
Points of Pride
Investments in Texas Biologics research have yielded results for disease prevention and treatment.
Patents since 2012
Raised via spinoff companies
Drugs in commercial use or development
News
Delivering a Better Life
The connection between research and real life is never so direct—or crucial—as it is in the field of health care.
